Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

559
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
559
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

13.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.9K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

6.8K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Kinase-Glo luminescent kinase assay for in vitro determination of PKA activity].

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology·2012
Same author

Functional characterization of an arrestin gene on insecticide resistance of Culex pipiens pallens.

Parasites & vectors·2012
Same author

MiR-23a inhibits myogenic differentiation through down regulation of fast myosin heavy chain isoforms.

Experimental cell research·2012
Same author

Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.

PloS one·2012
Same author

Role of IKK/NF-κB signaling in extinction of conditioned place aversion memory in rats.

PloS one·2012
Same author

Inhibition of poly(ADP-ribose) polymerase attenuates acute kidney injury in sodium taurocholate-induced acute pancreatitis in rats.

Pancreas·2012

Related Experiment Video

Updated: Mar 30, 2026

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

1.0K

Scutellarin Reduces Endothelium Dysfunction through the PKG-I Pathway.

Xiaohua Du1, Chen Chen2, Min Zhang3

  • 1School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China ; Department of Respiratory Medicine, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.

Evidence-Based Complementary and Alternative Medicine : Ecam
|November 12, 2015
PubMed
Summary

Scutellarin (SCU) protects against cerebral vascular issues by activating the endothelial cGMP-dependent protein kinase (PKG) pathway. This mechanism improves cell viability and restores blood vessel function in models of brain injury.

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.1K
Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
10:33

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells

Published on: November 18, 2022

1.8K

Related Experiment Videos

Last Updated: Mar 30, 2026

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

1.0K
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.1K
Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
10:33

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells

Published on: November 18, 2022

1.8K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • Vascular endothelium dysfunction (EtD) is a critical factor in cerebral ischemia.
  • Identifying protective agents targeting endothelial pathways is crucial for treating cerebrovascular diseases.

Purpose of the Study:

  • To investigate the protective mechanism of scutellarin (SCU) against vascular endothelium dysfunction.
  • To determine if SCU's protective effects involve the endothelial cGMP-dependent protein kinase (PKG) and vasodilator stimulated phosphoprotein (VASP) pathway.

Main Methods:

  • In vitro studies used human brain microvascular endothelial cells (HBMECs) subjected to hypoxia reoxygenation (HR).
  • In vivo studies utilized a rat model of cerebral ischemia reperfusion (CIR).
  • Evaluated protein and mRNA expression of PKG, VASP, and phosphorylated VASP (p-VASP) using Western blot and RT-PCR. Assessed vascular function via wire myography.

Main Results:

  • SCU treatment increased cell viability, PKG, VASP expression, and VASP phosphorylation in HBMECs under HR conditions.
  • In a rat basilar artery HR model, SCU elevated p-VASP levels.
  • In the rat CIR model, SCU reduced infarct size and partially restored endothelium-dependent vasodilation, an effect reversed by a PKG inhibitor.

Conclusions:

  • Scutellarin (SCU) demonstrates protective effects against cerebral vascular endothelium dysfunction.
  • The mechanism involves the activation of the endothelial PKG pathway.
  • SCU holds potential as a therapeutic agent for cerebrovascular disorders.